1,351
Views
9
CrossRef citations to date
0
Altmetric
Haematological malignancies

A phase II study to evaluate lenalidomide in combination with metronomic-dose cyclophosphamide in patients with heavily pretreated classical Hodgkin lymphoma

, , , , , , , & show all
Pages 933-938 | Received 16 Sep 2014, Accepted 08 Jan 2015, Published online: 03 Mar 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Viktor Wichmann, Natalja Eigeliene, Jatta Saarenheimo & Antti Jekunen. (2020) Recent clinical evidence on metronomic dosing in controlled clinical trials: a systematic literature review. Acta Oncologica 59:7, pages 775-785.
Read now
Theodoros Karantanos, Ioannis Politikos & Vassiliki A Boussiotis. (2017) Advances in the pathophysiology and treatment of relapsed/refractory Hodgkin’s lymphoma with an emphasis on targeted therapies and transplantation strategies. Blood and Lymphatic Cancer: Targets and Therapy 7, pages 37-52.
Read now
Sven Borchmann & Bastian von Tresckow. (2017) Novel agents in classical Hodgkin lymphoma. Leukemia & Lymphoma 58:10, pages 2275-2286.
Read now

Articles from other publishers (6)

Florian Lüke, Dennis C. Harrer, Karin Menhart, Daniel Wolff, Ernst Holler, Dirk Hellwig, Wolfgang Herr, Matthias Grube, Martin Vogelhuber, Albrecht Reichle & Daniel Heudobler. (2021) Biomodulatory Treatment Regimen, MEPED, Rescues Relapsed and Refractory Classic Hodgkin’s Disease. Frontiers in Pharmacology 12.
Crossref
Andreas Pircher, Normann Steiner & Eberhard Gunsilius. 2019. Tumor Angiogenesis. Tumor Angiogenesis 327 347 .
Richard Greil, Lisa Pleyer, Bettina Jansko, Carmen Feierabend, Lukas Rettenbacher, Olga Stiefel, Christoph Rass, Patrick Morre, Daniel Neureiter & Sigrun Greil-Ressler. (2018) Sequential immunotherapy in a patient with primary refractory Hodgkin lymphoma and novel mutations. Oncotarget 9:29, pages 20928-20940.
Crossref
Andreas Pircher, Normann Steiner & Eberhard Gunsilius. 2017. Tumor Angiogenesis. Tumor Angiogenesis 1 22 .
Rajendra Gharbaran. (2016) Insights into the molecular roles of heparan sulfate proteoglycans (HSPGs—syndecans) in autocrine and paracrine growth factor signaling in the pathogenesis of Hodgkin’s lymphoma. Tumor Biology 37:9, pages 11573-11588.
Crossref
Anna Dmoszyńska, Elżbieta Starosławska & Krzysztof Giannopoulos. (2015) Terapia metronomiczna w hematoonkologii: nadzieje i fakty. Acta Haematologica Polonica 46:5, pages 353-358.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.